Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF

Shranjeno v:
Bibliografske podrobnosti
izdano v:Circulation
Main Authors: Felker, G. Michael, Butler, Javed, Ibrahim, Nasiren E., Piña, Ileana L., Maisel, Alan, Bapat, Devavrat, Camacho, Alexander, Ward, Jonathan H., Williamson, Kristin M., Solomon, Scott D., Januzzi, James L.
Format: Artigo
Jezik:Inglês
Izdano: Lippincott Williams & Wilkins 2021
Teme:
Correspondence
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8270225/
https://ncbi.nlm.nih.gov/pubmed/34251893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.121.054034
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki